Proskauer advised Benitec Biopharma on the transaction. Benitec Biopharma (Nasdaq: BNTC), a development-stage, gene therapy-focused, biotechnology company, closed its recent capital raise. The aggregate gross proceeds to Benitec from...
You must be a Standard 1 Year member to access this content.
Proskauer advised advised Clean Earth Acquisitions Corp., while Baker Botts advised the underwriters on the deal. Clean Earth Acquisitions Corp. announced the pricing of its initial...
You must be a Standard 1 Year member to access this content.
Proskauer advised Heartland Media Acquisition Corp., while Davis Polk advised the underwriters in the offering. Heartland Media Acquisition Corp. executed the initial public offering of 17,500,000 units,...
You must be a Standard 1 Year member to access this content.
